[Medicinal chemistry targeting nucleosides and nucleic acids based on fine synthetic chemistry].
Nucleosides and nucleotides are one of the most important elements for cells by the fact that they are components of DNAs and RNAs. In addition, they play important roles in most fundamental cellular metabolic pathways such as energy donors, second messengers, and cofactors for various enzymes. Therefore, there exists a rich source in drug discovery targeting nucleosides and nucleotides. In order to utilize nucleosides and nucleic acids on the drug development, it is very important to develop reactions and methods, by which the highly coordinating and labile nucleoside intermediates can be used. With these in mind, we have been working on synthetic nucleoside and nucleic acid chemistry. First, branched sugar nucleoside derivatives, which are potential antitumor agents, have been synthesized utilizing samarium diiodide (SmI(2)) mediated Reformatsky reaction or aldol reaction. 3'-beta-Carbamoylmethylcytidine (CAMC) was found to exhibit potent cytotoxicity against various human tumor cell lines. Synthetic methodology of the caprazamycins, which are promising antibacterial nucleoside natural products, was also developed by the strategy including beta-selective ribosylation without using a neighboring group participation. Our synthetic route provided a range of key analogues with partial structures to define the pharmacophore. Simplification of the caprazamycins was further pursued to develop diketopiperazine analogs. Medicinal chemistry of oligodeoxynucleotides has been conducted. Thus, novel triazole-linked dumbbell oligodeoxynucleotides and modular bent oligodeoxynucleotides were synthesized. They exhibit excellent binding affinity to NF-kappaB or HMGB1 A-box protein, which are important therapeutic targets. Therefore, the results obtained conclusively demonstrated these oligodeoxynucleotides could be proposed as powerful decoy molecules.
Ichikawa
Satoshi
S
Faculty of Pharmaceutical Sciences, Hokkaido University, Japan. ichikawa@pharm.hokudai.ac.jp
D000818:Animals; D002625:Chemistry, Organic / Q000379:methods; D002626:Chemistry, Pharmaceutical / Q000379:methods; D015195:Drug Design; D024243:HMGB1 Protein; D006801:Humans; D007454:Iodides; D016328:NF-kappa B; D009696:Nucleic Acids / Q000138:chemical synthesis* / Q000502:physiology; D009705:Nucleosides / Q000138:chemical synthesis* / Q000502:physiology; D009838:Oligodeoxyribonucleotides / Q000138:chemical synthesis; D012493:Samarium
D024243:HMGB1 Protein; D007454:Iodides; D016328:NF-kappa B; D009696:Nucleic Acids; D009705:Nucleosides; D009838:Oligodeoxyribonucleotides; D012493:Samarium; C409809:samarium diiodide